产品名称 AZD 3463
产品货号 Axon 2153 CAS [1356962-20-3] MF C24H25ClN6OMW 448.95 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description Potent inhibitor of Anaplastic Lymphoma Kinase (ALK) and IGF1R; AZD3463 is potent in ALK-driven preclinical models and in a variety of crizotinib-resistant models References Certificates Categories Extra info Discovery of AZD3463 as a Novel ALK/IGFR Dual Inhibitor and its Ability in Overcoming Acquired Resistance to Crizotinib. Presented by B Yang at 8th Protein Kinases in Drug Discovery 2013, Boston USA.    Concurrent roles for IGF1R and EGFR in driving acquired resistance to crizotinib and ability to overcome with a combination of the ALK/IGF1R inhibitor AZD3463 and Iressa. Abstr. 4465 presented by L Drew et al. AACR Annual Meeting 2013 Washington DC USA.  Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology ALK Endocrinology TGF-β RTK class II and XIX; EC 2.7.10.1 Potent inhibitor of ALK and IGF1R Chemical name N-(4-(4-aminopiperidin-1-yl)-2-methoxyphenyl)-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine Parent CAS No. [1356962-20-3] Order Size Unit Price Stock 5 mg €105.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

AZD 3463

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 2153

CAS [1356962-20-3]

MF C24H25ClN6O
MW 448.95

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

AZD 3463

Description

Potent inhibitor of Anaplastic Lymphoma Kinase (ALK) and IGF1R; AZD3463 is potent in ALK-driven preclinical models and in a variety of crizotinib-resistant models
产品资料